Skip to main content
Market intelligence
AUPHHealthcare

Aurinia Pharmaceuticals Inc insider activity

In the last 90 days, 2 corporate insiders purchased $24,910,489 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$24,910,489
Corporate buyers
2
Latest transaction
Jun 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 2, 2026Kevin TangChief Executive OfficerOpen Market Purchase814,606$15.29$12,455,244
Jun 2, 2026Tang Capital Management LlcCorporate insiderOpen Market Purchase814,606$15.29$12,455,244